
Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, …

The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma. Gilead’s treatment will …

Medicines are costing the NHS more than 50% more than a decade ago, while hospitals are paying more than twice …
Mylan’s EpiPen woes show no sign of abating after CMS (Centers for Medicare and Medicaid Services) released figures that show …

A recent exposé has shone a light on the practices allegedly enforced at the nation’s largest pharmacy. So what exactly …

AbbVie, Humira (adalimumab), £371m. This drug treats a variety of conditions including psoriatic arthritics, Crohn’s disease and ulcerative colitis. The …

As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …